Cancer BiologyDrug Resistance UpdatesPeer-reviewed
MZF1-mediated GAPDH overexpression drives glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer
Wang Liu, Lily He, Cuncong Zhong…·Benyi Li
This study identifies MZF1-mediated GAPDH overexpression as a driver of glycolytic reprogramming and neuroendocrine progression in advanced prostate cancer, suggesting metabolic targeting as a therapeutic strategy.
1 citationtop 4%